SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sonoma Pharmaceuticals Q2 FY27 net loss narrows 88% to $66,000

Sonoma Pharmaceuticals Q2 FY27 net loss narrows 88% to $66,000 Sonoma Pharmaceuticals’ second-qu

SNOA

Related stories